6C8L
EQ1: 2-amino-1-[(R)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-3-[(S)-{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]-1H-imidazol-3-ium
EQ1 is a Ligand Of Interest in 6C8L designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6C8L_EQ1_A_101 | 65% | 1% | 0.111 | 0.912 | 3.88 | 3.47 | 16 | 18 | 0 | 0 | 100% | 1 |
| 6C8L_EQ1_B_101 | 63% | 1% | 0.12 | 0.914 | 3.8 | 3.84 | 15 | 21 | 0 | 0 | 100% | 1 |
| 6C8N_EQ1_A_102 | 82% | 3% | 0.103 | 0.958 | 3.23 | 2.78 | 14 | 15 | 0 | 0 | 100% | 0.4 |
| 6C8K_EQ1_B_101 | 75% | 2% | 0.11 | 0.943 | 3.35 | 3.28 | 12 | 15 | 0 | 0 | 100% | 1 |
| 6C8M_EQ1_A_102 | 75% | 1% | 0.115 | 0.947 | 4.16 | 3.42 | 17 | 17 | 0 | 0 | 100% | 0.8 |
| 6C8E_EQ1_B_101 | 65% | 2% | 0.127 | 0.93 | 3.21 | 3.36 | 14 | 18 | 0 | 0 | 100% | 1 |
